Increasing Comfort That NuCana's (NCNA) Phase 3 Data Will Perform to Expectations, Shares Are Compelling - Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Leland Gershall reiterated an Outperform rating and $19.00 price target on NuCana (NASDAQ: NCNA), ahead of the upcoming ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
